Event: First Status Conference Date Set Date: February 16, 2024 Notes: Judge Pratter announces that the first status conference of the Ozempic lawsuit will be on March 14, 2024
While the price of $149 for the starting dose is lower than what the companies currently offer for the injectable drugs, that price is only for the initial, lowest dose
Retrieved from Sodhi, M., Rezaeianzadeh, R., Kezouh, A., et al
Sources: GLP-1 Agonists: What They Are, How They Work & Side Effects (clevelandclinic.org) GLP-1 Medications: Everything You Need to Know (healthline.com) Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss | FDA FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA FDA Approves New Medication for Chronic Weight Management | FDA Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients (pharmacytimes.com) Popular GLP-1 Agonists List, Drug Prices and Medication Information - GoodRx Relationship between diet/exercise and pharmacotherapy to enhance the GLP1 levels in type 2 diabetes - PMC (nih.gov)
C., Perez, E., Rapuano, A., Sandhu, M
Dysesthesia means unusual skin sensitivity, tingling, or tenderness to touch